Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s):  CRDL | T.CRDL.W.A

Cardiol Therapeutics Inc. (Cardiol) is a Canada-based clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). The Company's lead product, CardiolRx, is a pharmaceutically produced oral cannabidiol formulation that is in a Phase II/III study in hospitalized patients testing positive... see more

TSX:CRDL - Post Discussion

Cardiol Therapeutics Inc > Today in the Financial News…
View:
Post by Youhillman on Apr 14, 2022 4:03pm

Today in the Financial News…

Nice run today....this was published today in the Financial News...maybe part of the reason.

I've sold off most of what I owned in the $4-5 profit range as I've been disappointed with Cardiol's follow through on some of their previous stated business opportunities but hold enough to still make some serious coin if this thing flies....

https://www.the-financialnews.com/heres-how-investors-can-make-2000-with-this-stock/?gclid=Cj0KCQjwjN-SBhCkARIsACsrBz5Io-zkGBtDMrZ4WcEncUdkYsIJIxgXe-9yNl0iCO957iYfny-2MBYaAvj3EALw_wcB

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities